Can You Get Mounjaro with a BMI Below 40 in the UK? 2026 Guide

Yes — most UK users getting Mounjaro in 2026 have a BMI below 40. The NHS route currently requires BMI 40+ with comorbidities, but the private route has its own criteria which start at BMI 30 (or 27.5 with weight-related conditions). This post walks through what the real eligibility thresholds are for each route, what evidence you’ll need to qualify, and honest advice on what to do if you’re at BMI 28, 32, or 37 and wondering whether the medication is for you.

For the broader sourcing picture see How to Get Mounjaro in the UK. For eligibility specifically: Am I Eligible for Mounjaro UK?.

The eligibility landscape in April 2026

There are three distinct routes with three distinct sets of criteria:

Route 1: NHS Cohort 1 (currently the only NHS weight-management pathway)

Eligibility requires both:

• BMI of 40 or above (35 or above for adults from certain ethnic backgrounds at higher metabolic risk at lower BMIs — South Asian, Chinese, Black, Middle Eastern)
• At least 4 of 5 qualifying comorbidities: type 2 diabetes, hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea

If you’re below BMI 40 and not in a higher-risk ethnic group at lower BMI threshold, or if you don’t have 4+ comorbidities, you’re not currently in NHS Cohort 1.

Route 2: Private prescribing (CQC/GPhC-registered online providers and high-street pharmacies)

The eligibility criteria private prescribers use are broadly aligned with the NICE guidance that underpinned Mounjaro’s UK authorisation for weight management. Most private UK providers in 2026 use something close to:

• BMI of 30 or above, OR
• BMI of 27.5–29.9 with at least one weight-related condition (prediabetes, type 2 diabetes, hypertension, high cholesterol, cardiovascular disease, obstructive sleep apnoea, PCOS, non-alcoholic fatty liver disease)

Some providers are slightly stricter (BMI 30+ required regardless of comorbidities; some use 28 as their absolute floor); some are marginally more liberal.

Providers won’t typically prescribe at BMI below 27.5 regardless of what you tell them. The exceptions are edge cases like a borderline BMI combined with strong clinical history — those tend to require a video consultation rather than a standard form-based prescription.

Route 3: Private prescribing for type 2 diabetes (separate pathway)

Mounjaro is also licensed for type 2 diabetes. Diabetes prescribing uses different criteria (HbA1c, existing diabetes medication history) rather than BMI alone. If you have type 2 diabetes and need better glucose control, that pathway is separate from the weight management pathway — even if weight loss is also a goal.

What the private BMI thresholds actually mean

The 30+ threshold sits roughly at:

• 5’4″ (1.63m): 77.8kg (12 stone 3 lb)
• 5’6″ (1.68m): 82.6kg (13 stone 0 lb)
• 5’8″ (1.73m): 89.8kg (14 stone 2 lb)
• 5’10” (1.78m): 95.1kg (14 stone 13 lb)
• 6’0″ (1.83m): 100.4kg (15 stone 11 lb)
• 6’2″ (1.88m): 106.0kg (16 stone 10 lb)

The 27.5–29.9 range (eligible with a comorbidity) sits roughly 4–6kg (9–13 lb) below the 30+ line.

See our BMI Explained UK guide for the full height-weight-BMI chart.

What counts as a qualifying comorbidity

At the 27.5–29.9 BMI range, what tips you from “not eligible” to “eligible” is having at least one documented weight-related condition. The conditions most providers accept:

• Type 2 diabetes — via HbA1c test result, typically ≥48 mmol/mol (6.5%)
• Prediabetes — HbA1c 42–47 mmol/mol
• Hypertension — documented high blood pressure, with or without treatment
• High cholesterol / dyslipidaemia — documented abnormal lipid panel
• Cardiovascular disease — previous heart attack, stroke, angina, stented vessels, diagnosed heart failure
• Obstructive sleep apnoea — diagnosed via sleep study, with or without CPAP
• PCOS (polycystic ovary syndrome) — diagnosed by gynaecologist or GP
• Non-alcoholic fatty liver disease (NAFLD) — typically via ultrasound or LFTs
• Previous gestational diabetes (some providers)
• Severe joint disease linked to weight (some providers)

What you’ll need to document: typically a summary care record extract, recent blood test results, or a letter from your GP confirming the diagnosis. Some providers accept self-declaration if your GP record isn’t readily accessible; most prefer documentation.

What if you’re BMI 25–27.5?

This is the “normal/upper-normal” BMI range where someone may want to lose weight but sits below standard private prescribing thresholds.

Honest answer: almost no legitimate UK private provider will prescribe Mounjaro to someone in this range for weight management. The clinical reasoning:

• The risk-benefit calculation changes at normal weights — GLP-1 side effects and rare risks are weighed against less significant cardiovascular and metabolic gains
• Rapid weight loss from a lower starting point has different implications for bone density, muscle mass, and hormonal balance than weight loss from a higher starting point
• Regulatory authorisation covers obesity and overweight-with-comorbidity; prescribing outside that is off-label and most UK prescribers won’t do it

What some people do instead (the grey market of overseas pharmacies, offshore telemedicine, or black-market supply) carries real legal and safety risks — counterfeit product, interaction with unchecked medical history, no clinical oversight. See the Fake Mounjaro Counterfeit UK post for what to watch out for.

If you’re in the 25–27.5 range and genuinely struggling with weight, the evidence-based options are nutrition and exercise work with a registered dietitian, investigation of underlying causes (thyroid, hormonal, sleep, medication-related), and time. Mounjaro is not appropriate territory for this range in 2026 UK private practice.

What if you’re BMI 27.5–29.9 without an obvious comorbidity?

This is the edge case where you’re close to eligibility but haven’t been formally diagnosed with any of the qualifying conditions. A few practical steps:

1. Get actual tests done. Many people in this BMI range have undiagnosed prediabetes, borderline hypertension, or dyslipidaemia. A basic blood panel plus a home blood pressure reading may surface something that qualifies you.

2. Book an NHS Health Check. If you’re 40–74, you’re eligible for a free NHS Health Check every 5 years. This covers cholesterol, blood pressure, HbA1c, and BMI. Free, takes an hour, may identify a qualifying condition you didn’t know about.

3. See your GP about specific symptoms. If you’ve had any symptoms that suggest sleep apnoea (loud snoring, daytime sleepiness, witnessed pauses in breathing), PCOS (irregular periods, unwanted hair growth, fertility struggles), or fatty liver (persistent fatigue, elevated liver enzymes in past blood tests), those are conversations worth having.

4. Don’t fabricate a comorbidity. Tempting at the edges, but self-declaring a condition you don’t have is medical fraud, and good prescribers will catch it by requesting documentation. You lose the prescription and potentially your access to that provider.

What if your BMI fluctuates around the threshold?

Common scenario: your BMI was 31 six months ago when you started thinking about Mounjaro, and now after some initial weight loss it’s 29. Are you still eligible?

Most providers use your current BMI at the time of prescribing, not historical BMI. So if you’re 29.5 today, without a qualifying comorbidity, you’re below threshold today.

What some providers will consider: if you have documented history of BMI 30+ within the last 12–24 months and a pattern of weight regain, that history can be taken into account. Bring the evidence (weight records, old GP records, photos). This is a judgement call for the prescriber.

The ‘should I delay starting until my BMI is higher’ question

This question comes up occasionally: “I’m 29.8 BMI now without any qualifying condition. Should I gain 2kg to get into the 30+ range and qualify?”

Please don’t. Three reasons:

1. It’s medically illogical. Deliberately gaining weight to qualify for a weight-loss medication is a strange proposition and good prescribers will see through it in the consultation.

2. The 2kg gain takes longer than you’d think to reverse. You gain 2kg in 6 weeks easily; on Mounjaro starting from 2.5mg you’ll take 2–3 months to lose it. Net zero at best.

3. You may qualify another way. Many people at 28–30 BMI have undiagnosed prediabetes or hypertension. Get tests first.

NHS Cohort 2 and future expansion

NHS England has signalled phased expansion of weight management medication access through 2026–2027 under Cohort 2. Expected expansion:

• Lowering BMI threshold to 35 (with fewer comorbidities)
• Potentially to BMI 30 with qualifying conditions in later phases

As of April 2026, the specific Cohort 2 rollout timeline and criteria are still being finalised. Check the NHS England weight management medicines page for current status.

If you’re in the 30–35 BMI range and don’t meet Cohort 1 criteria, the practical choice is: go private now, or wait for Cohort 2 expansion. Most people in this position don’t wait — there’s no guaranteed Cohort 2 date, weight gain typically continues meanwhile, and private costs are high but not prohibitive.

The specific conversation to have with your GP

If you’re below BMI 40 and want your GP involved (even if you’ll end up going private), the productive conversation is:

1. “I’d like a metabolic health check.” Request blood pressure, fasting glucose, HbA1c, fasting lipid panel, and liver function tests. These identify most qualifying comorbidities if they exist.

2. “I’m considering weight management medication through private channels.” Ask your GP to document this on your record so it’s there when you go private and want to notify your NHS GP.

3. “I’d like your input on whether there are underlying causes we should investigate.” Sleep apnoea screening, thyroid function, PCOS assessment if relevant, medication review if you’re on anything known to affect weight.

This conversation gets you either: eligibility documentation, a reason to pause and try a different approach, or a clean record showing you’ve done due diligence before going private.

What good private providers do when your BMI is borderline

At BMI 27.5–29.9 with a documented comorbidity, a good private provider will:

• Ask for specific documentation of the comorbidity rather than accepting self-declaration
• Request a video consultation rather than form-only assessment
• Be more conservative on titration speed
• Check in more frequently through the first 3 months
• Advise caution on target weights that would push below BMI 22–23

If a provider is happy to prescribe at 28 BMI with no comorbidity documentation and no extra checks, that’s a sign to choose a different provider. The safeguards exist for a reason.

The bottom line

Below BMI 40 is where most UK Mounjaro users are. The private route is available and legitimate at BMI 30+ or 27.5+ with a comorbidity. Below 27.5 is genuinely outside standard UK prescribing territory. The NHS route will expand in 2026–2027 but the timeline is uncertain; for most non-Cohort-1 patients, private is the practical path today.

For the process of going private: Mounjaro Online Prescription UK. For cost comparison: Cheapest Mounjaro Provider UK 2026. For everything else: the Complete GLP-1 Weight Loss Guide.

Medical note: eligibility criteria are clinical and individual; this is a general guide to typical provider thresholds in 2026, not a guarantee of approval. Each provider makes its own clinical judgements.